𝔖 Bobbio Scriptorium

✦ LIBER ✦

An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells

✍ Scribed by Nyormoi, O; Mills, L; Bar-Eli, M

Book ID: 110016537
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 448 KB
Volume: 10
Category: Article
ISSN: 1350-9047
DOI: 10.1038/sj.cdd.4401209

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

197 A phase I and pharmacokinetic (PK) s

197 A phase I and pharmacokinetic (PK) study of an agonistic, fully human monoclonal antibody, HGS-ETR2, to the TNF-alpha related apoptosis inducing ligand receptor 2 (TRAIL R2) in patients with advanced cancer

✍ J. de Bono; G. Attard; R. Plummer; S. Pacey; C. Bale; L. Vidal; A. Greystoke; N. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Zoledronic acid in combination with seri

Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A

✍ Yalcin Cirak; Umut Varol; Harika Atmaca; Asli Kisim; Canfeza Sezgin; Bulent Kara 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

Drug interactions between the proteasome

Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF), and TNF-related apoptosis-inducing ligand (TRAIL) in prostate cancer: An J, Sun Y-P, Adams J, Fisher M, Belldegrun A, Rettig MB, Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, CA [J An, Y-PS, MF, MBR]; Millennium Pharmaceuticals, Inc., Cambridge, MA [J Adams]; and University of California at Los Angeles School of Medicine, Los Angeles, CA [AB, MBR]. Clinical Cancer Research 2003;9:4537–4545

✍ Gurkamal Chatta 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 18 KB